TBO.com: Tampa Bay Online, The Tampa Tribune and The Tampa Times - breaking news and weather.
Monday, Sep 01, 2014
Rays

Rays’ Colome suspended 50 games for drug violation

By
Published:   |   Updated: March 25, 2014 at 06:33 AM

FORT MYERS — Rays pitching prospect Alex Colome was suspended 50 games without pay for violating Major League Baseball’s Joint Drug Prevention and Treatment Program after testing positive for Boldenone, a performance-enhancing substance.

Colome made three starts for the Rays last season, earning a victory against the Miami Marlins in May. The right-hander is considered one of the Rays’ top pitching prospects and was set to begin the season at Triple-A Durham.

The suspension begins at the start of the season.

Boldenone is an anabolic steroid commonly used to treat horses.

The Rays issued this statement: “We were disappointed to learn of Alex Colome’s violation of Major League Baseball’s Joint Drug Prevention and Treatment Program. We fully support Major League Baseball’s policy and its efforts to eliminate performance-enhancing substances from our game. Per the protocol outlined in the Joint Drug Program, the organization will not comment further on this matter.”

Colome had two stints with the Rays in 2013. He was called up in late May for a spot start against the Marlins and became the seventh pitcher in team history to win his major league debut.

Colome returned in late June and made a pair of starts. He did not receive a decision after pitching 4 2/3 innings against the Yankees in New York and picked up the loss after allowing four runs in six innings against the Tigers. Those were the only runs he allowed in his three starts.

That also would be Colome’s last appearance of the season. He returned to Durham and was placed on the disabled list with a right elbow strain. It was the second straight year Colome suffered a season-ending injury. He was shelved in mid-August 2012 because of right shoulder tightness.

rmooney@tampatrib.com(813) 259-7227

Twitter: @RMooneyTBO

Subscribe to The Tampa Tribune

Comments